Company intelligence / Profile preview

Endymion Medical

Ownership: Private
Employees: ~46
Development stage: Other

Overview

EndyMed’s proprietary FDA-cleared 3DEEP radiofrequency technology is clinically validated and powers both professional and home-use devices for non-invasive skin rejuvenation, body contouring, microneedling, fractional skin resurfacing, wrinkle and scar treatment, and skin tightening. The company has a global presence with strong sales in Asia/Oceania, Europe, North America, and Latin America[3][5][6].

Therapeutic areas: DermatologyOther
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Major distribution partnership/merger with Shanghai Haohai Biological Technology Co., Ltd.

Beyond the preview

Go deeper on Endymion Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endymion Medical.

Explore the full profile